Apr 7, 2005 by Stephen D. SimpsonAlcoa Won't Be FoiledDespite high input costs, Alcoa is still benefiting from the upturn in aluminum.
Apr 7, 2005 by Stephen D. SimpsonCardioDynamics' Code BlueInvesting in small-cap medical technology requires patience, but CardioDynamics is starting to push its luck.
Apr 7, 2005 by Stephen D. SimpsonShould RPM Get You Revving?Higher prices are squeezing this maker of specialty coatings and sealants. Will brand value save the day?
Apr 7, 2005 by Stephen D. SimpsonUTi Expedites Global GrowthThis large freight forwarder continues to benefit from international trade, but rising costs are a concern.
Apr 7, 2005 by Stephen D. SimpsonA New China Yuchai?An agreement between China Yuchai and Coomber looks promising, but we've heard this before.
Apr 6, 2005 by Stephen D. SimpsonInternational Speedway in High GearAttendance and sponsorship aren't letting up for this racetrack operator.
Apr 6, 2005 by Stephen D. SimpsonShould Investors Rely Upon Reliance?Large metal processor pre-announces a strong first quarter.
Apr 6, 2005 by Stephen D. SimpsonInvesting in Controlling ObesityA look at radical treatments for obesity and the companies behind them -- plus the backlash against the food industry.
Apr 6, 2005 by Stephen D. SimpsonA True ScrapperSchnitzer reports a good quarter, but the future is beginning to look more challenging.
Apr 6, 2005 by Stephen D. SimpsonShaw Share Sale Sinks StockShaw's move to sell shares will firm up the balance sheet, but the market doesn't like the dilution.
Apr 5, 2005 by Stephen D. SimpsonOM Group Mops Up MessRestructuring, restating, and shareholder suits have bedeviled this metal products company.
Apr 5, 2005 by Stephen D. SimpsonCan Obesity Fatten Your Wallet?Obesity is an increasingly serious problem, but could it also be a major opportunity for health-care companies?
Apr 5, 2005 by Stephen D. SimpsonMSC Industrial Thinks SmallThis industry supply house offers a broad play on manufacturing growth.
Apr 5, 2005 by Stephen D. SimpsonPfizer Pfaces Its PfutureAnalysts and investors seem happy with Pfizer's long-term strategy. Should they be?
Apr 4, 2005 by Stephen D. SimpsonChevronTexaco Devours UnocalChevronTexaco adds reserves and production at a reasonable price.
Apr 4, 2005 by Stephen D. SimpsonLearn to Respect ShortsIf people would just stop shouting, they might learn something.
Mar 31, 2005 by Stephen D. SimpsonStrike Three for TysabriA third confirmed case of PML all but eliminates Tysabri's potential as a blockbuster drug.
Mar 31, 2005 by Stephen D. SimpsonAnother "No" for LexaproThis latest FDA setback shouldn't hurt Forest Labs much, and the shares look like a bargain.
Mar 31, 2005 by Stephen D. SimpsonThe DOJ Goes Fishing for OrthopedicsThe government's industrywide investigation of orthopedics is more of a buying opportunity than a real threat.
Mar 31, 2005 by Stephen D. SimpsonSmall Cap Drills DifferentlyGas producer Petroleum Development has a different operating structure, but it seems to be working.
